Francis Collins, the former head of the National Human Genome Research Institute, has had his genome analyzed by the big three of direct-to-consumer genetic testing: 23andMe, Navigenics, and DecodeMe.

He found significant differences in the numbers of genetic variations used to calculate disease risk, as well as the final risk score.